292 related articles for article (PubMed ID: 23709605)
41. D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR.
Eden G; Archinti M; Arnaudova R; Andreotti G; Motta A; Furlan F; Citro V; Cubellis MV; Degryse B
Cell Mol Life Sci; 2018 May; 75(10):1889-1907. PubMed ID: 29184982
[TBL] [Abstract][Full Text] [Related]
42. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis.
Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687
[TBL] [Abstract][Full Text] [Related]
43. Mapping the interaction between high molecular mass kininogen and the urokinase plasminogen activator receptor.
Mahdi F; Shariat-Madar Z; Kuo A; Carinato M; Cines DB; Schmaier AH
J Biol Chem; 2004 Apr; 279(16):16621-8. PubMed ID: 14764580
[TBL] [Abstract][Full Text] [Related]
44. Urokinase-type Plasminogen Activator (uPA) Binding to the uPA Receptor (uPAR) Promotes Axonal Regeneration in the Central Nervous System.
Merino P; Diaz A; Jeanneret V; Wu F; Torre E; Cheng L; Yepes M
J Biol Chem; 2017 Feb; 292(7):2741-2753. PubMed ID: 27986809
[TBL] [Abstract][Full Text] [Related]
45. Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling.
Tarui T; Andronicos N; Czekay RP; Mazar AP; Bdeir K; Parry GC; Kuo A; Loskutoff DJ; Cines DB; Takada Y
J Biol Chem; 2003 Aug; 278(32):29863-72. PubMed ID: 12754207
[TBL] [Abstract][Full Text] [Related]
46. Regulation of single chain urokinase binding, internalization, and degradation by a plasminogen activator inhibitor 1-derived peptide.
Zhang L; Strickland DK; Cines DB; Higazi AA
J Biol Chem; 1997 Oct; 272(43):27053-7. PubMed ID: 9341144
[TBL] [Abstract][Full Text] [Related]
47. Enhancement of the enzymatic activity of single-chain urokinase plasminogen activator by soluble urokinase receptor.
Higazi A; Cohen RL; Henkin J; Kniss D; Schwartz BS; Cines DB
J Biol Chem; 1995 Jul; 270(29):17375-80. PubMed ID: 7615542
[TBL] [Abstract][Full Text] [Related]
48. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.
Yebra M; Goretzki L; Pfeifer M; Mueller BM
Exp Cell Res; 1999 Jul; 250(1):231-40. PubMed ID: 10388537
[TBL] [Abstract][Full Text] [Related]
49. Participation of the urokinase-type plasminogen activator receptor (uPAR) in neutrophil transendothelial migration.
Pliyev BK; Antonova OA; Menshikov M
Mol Immunol; 2011 May; 48(9-10):1168-77. PubMed ID: 21470685
[TBL] [Abstract][Full Text] [Related]
50. Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasion.
Bifulco K; Longanesi-Cattani I; Franco P; Pavone V; Mugione P; Di Carluccio G; Masucci MT; Arra C; Pirozzi G; Stoppelli MP; Carriero MV
PLoS One; 2012; 7(9):e44806. PubMed ID: 23049759
[TBL] [Abstract][Full Text] [Related]
51. Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells.
Jo M; Eastman BM; Webb DL; Stoletov K; Klemke R; Gonias SL
Cancer Res; 2010 Nov; 70(21):8948-58. PubMed ID: 20940399
[TBL] [Abstract][Full Text] [Related]
52. Urokinase-type plasminogen activator receptor is involved in mediating the apoptotic effect of cleaved high molecular weight kininogen in human endothelial cells.
Cao DJ; Guo YL; Colman RW
Circ Res; 2004 May; 94(9):1227-34. PubMed ID: 15044324
[TBL] [Abstract][Full Text] [Related]
53. A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction.
Liu D; Zhou D; Wang B; Knabe WE; Meroueh SO
ACS Chem Biol; 2015 Jun; 10(6):1521-34. PubMed ID: 25671694
[TBL] [Abstract][Full Text] [Related]
54. An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration.
Mazzieri R; D'Alessio S; Kenmoe RK; Ossowski L; Blasi F
Mol Biol Cell; 2006 Jan; 17(1):367-78. PubMed ID: 16267271
[TBL] [Abstract][Full Text] [Related]
55. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
[TBL] [Abstract][Full Text] [Related]
56. Ascites induces modulation of alpha6beta1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma.
Ahmed N; Riley C; Oliva K; Rice G; Quinn M
Br J Cancer; 2005 Apr; 92(8):1475-85. PubMed ID: 15798771
[TBL] [Abstract][Full Text] [Related]
57. Nicotine stimulates urokinase-type plasminogen activator receptor expression and cell invasiveness through mitogen-activated protein kinase and reactive oxygen species signaling in ECV304 endothelial cells.
Khoi PN; Park JS; Kim NH; Jung YD
Toxicol Appl Pharmacol; 2012 Mar; 259(2):248-56. PubMed ID: 22261521
[TBL] [Abstract][Full Text] [Related]
58. Plasminogen activator inhibitor-1 inhibits angiogenic signaling by uncoupling vascular endothelial growth factor receptor-2-αVβ3 integrin cross talk.
Wu J; Strawn TL; Luo M; Wang L; Li R; Ren M; Xia J; Zhang Z; Ma W; Luo T; Lawrence DA; Fay WP
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):111-20. PubMed ID: 25378411
[TBL] [Abstract][Full Text] [Related]
59. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
60. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells.
Tang H; Kerins DM; Hao Q; Inagami T; Vaughan DE
J Biol Chem; 1998 Jul; 273(29):18268-72. PubMed ID: 9660790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
